evernorth glp-1 New EnReachRx model expands its suite of solutions Evernorth expands program to help

So, against my doctor's sage advice I tried a GLP-1

Stuck on your GLP-1 journey

This review article discusses the potential antidepressant effects of GLP-1RAs, especially in the context of their action on the processes related to neuroprotection, inflammation, stress response, energy metabolism, gut-brain crosstalk and the stability of the gut microbiota

In this article, we explore how pairing NAD+ therapy with GLP-1s works and why it may help you reach your goals more effectively

Zealand Pharma's agreement with Roche to jointly develop and commercialise an experimental amylin-based weight-loss treatment will create a strong obesity trea

This was attributed to insulin deficiency and vomiting-induced acid loss and bicarbonate retention